Abstract
The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 283-288 |
| Number of pages | 6 |
| Journal | Drugs of the Future |
| Volume | 43 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2018 |
Keywords
- ALT-803
- Lefitolimod
- MB66
- Novel formulations
- Pembrolizumab
- VRC07-523LS
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)